Intervacc AB (publ) (STO:IVACC)
0.6600
-0.0180 (-2.65%)
Nov 20, 2026, 5:29 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 224.94 million as of November 20, 2026. It is the 35,619th most valuable company in the world and the 488th biggest in Sweden. Its market cap has decreased by 29.03% in one year.
Market Cap
224.94M
Enterprise Value
126.25M
Revenue
17.35M
Global Rank
Country Rank
#488 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 224.94M, an increase of 162.18%. That is a compound annual growth rate of 10.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 224.94M | -28.57% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 365.86M |
| Cantargia AB | 363.43M |
| Isofol Medical AB | 317.29M |
| Mendus AB | 217.29M |
| Xbrane Biopharma AB | 213.27M |
| Initiator Pharma | 171.13M |
| Elicera Therapeutics AB | 164.51M |
| Abera Bioscience AB | 140.62M |